Abstract
“Cardiac syncope” comprises those causes of syncope that are primarily due to disturbances of cardiac or cardiovascular function.1 Thus, cardiac conduction system disease, primary cardiac rhythm disturbances, and cardiovascular structural abnormalities are incorporated within this category (previously “cardiac arrhythmias” and “structural cardiac and cardiovascular disease” were considered as separate classes2,3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.
Brignole M, et al. Guidelines on management (diagnosis and treatment) of syncope. Europace. 2004;6:467–537.
Jhanjee R, et al. Syncope. Mosby: Disease-a-Month; 2009:527–586.
Soteriades ES, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885.
Savage DD, et al. Epidemiologic features of isolated syncope: The Framingham Study. Stroke. 1985;16:626–629.
Pires LA, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. Am J Cardiol. 2000;85:725–728.
Olshansky B, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J. 1999;137:878–886.
Steinberg JS, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics versus implantable defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001.
Knight BP, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.
Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.
Sauer A, et al. Long QT Syndrome in Adults. J Am Coll Cardiol. 2007;49:329–337.
Sacher F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A Multicenter Study. Circulation. 2006;114:2317–2324.
Sarkozy A, et al. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334–344.
Paparella G, et al. Brugada syndrome: The prognostic dilemma and value of syncope. Minerva Med. 2009;100:307–319.
Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: A meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–2133.
Alboni P, et al. The diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37:1921–1928.
Del Rosso A, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005;96:1431–1435.
Del Rosso A, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008;94:1620–1626.
Colivicchi F, et al. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749–1753.
Benditt DG, et al. Sinus node dysfunction. In: Willerson JT, Cohn JN, eds. Cardiovascular Medicine. 3rd edn. Edinburgh: Churchill Livingstone; 2006:1925–1935.
Benditt DG, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;75(Suppl III):93–99.
Raj S. Highlights in clinical autonomic neurosciences. Orthostatic tachycardia and orthostatic hypotension. Autonom Neurosci Basic and Clin. 2010;154:1–2.
Gann D, et al. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979;90:24–29.
Fragakis N, et al. The value of adenosine test in the diagnosis of sick sinus syndrome: susceptibility of sinus and atrioventricular node to adenosine in patients with sick sinus syndrome and unexplained syncope. Europace. 2007;9:559–562.
Flammang D, et al. The adenosine triphosphate (ATP) test for evaluation of syncope of unknown origin. J Cardiovasc Electrophysiol. 2005;16:1388–1389.
Perennes A, et al. Epidemiology, clinical features, and follow-up of patients with syncope and a positive adenosine triphosphate test result. J Am Coll Cardiol. 2006;47:594–597.
Brignole M, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006;27:2232–2239.
Menozzi C, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745.
Brignole M, et al. Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001;104:2045–2050.
Brignole M, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Task Force members. Europace. 2009;11:671–687.
Brignole M, et al. Improved arrhythmia detection in implantable loop recorders. J Cardiovasc Electrophysiol. 2008;19:928–934.
Villain E. Indications for pacing in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008;31(Suppl 1):S17–S20.
Michaelsson M, et al. A natural history of congenital atrio-ventricular block. Pacing Clin Electrophysiol. 1997;20:2098–2101.
Camm AJ, Lau CP. Syncope of undetermined origin: diagnosis and management. Prog Cardiol. 1988;1:139–156.
Maron BJ, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113:1807–1816.
Corrado D, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091.
Maron BJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–2816.
Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009;6:984–992.
Farzaneh-Far A, Lerman BB. Idiopathic ventricular outflow tract tachycardia. Heart. 2005;91:136–138.
Chun KR, et al. Left ventricular outflow tract tachycardia including ventricular tachycardia from the aortic cusps and epicardial ventricular tachycardia. Herz. 2007;32:226–232.
Jackman WM, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988;31:115–172.
Moss AJ, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–1144.
Schwartz PJ, et al. Stress and sudden death: the case of the long QT syndrome. Circulation. 1991;83(Suppl II):71–80.
Moss AJ, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929–2934.
Zareba W, Cygankiewicz I. Long QT syndrome and short QT syndrome. Prog Cardiovasc Dis. 2008;51:264–278.
Johnson JN, Ackerman MJ. QTc: How long is too long? Br J Sports Med. 2009;43:657–662.
Colman N, et al. Value of history-taking in syncope patients: In whom to suspect long QT syndrome?. Europace. 2009;11:937–943.
Antzelevitch C, et al. Brugada syndrome: report of the second consensus conference. Circulation. 2005;111:659–670.
Spirito P, et al. Implantable cardioverter defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Am Med Assoc. 2007;298:405–412.
Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703–1710.
Nallamothu BK, et al. Syncope in acute aortic dissection: Diagnostic, prognostic and clinical implications. Am J Med. 2002;113:468–471.
Krahn AD, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104:46–51.
Krahn AD, et al. Cost implications of testing strategy in patients with syncope. Randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42:495–501.
Brignole M, et al. Early application of an implantable loop recorder allows a mechanism-based effective therapy in patients with recurrent suspected neurally-mediated syncope. Eur Heart J. 2006;27:1085–1092.
Morady F, et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol. 1983;2:1053–1059.
Sra JS, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 1991;114:1013–1019.
Fujimura O, et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by bradycardia. N Engl J Med. 1989;321:1703–1707.
Brembilla-Perrot B, et al. Are the results of electrophysiological study different in patients with a pre-excitation syndrome, with and without syncope? Europace. 2008;10:175–180.
Brembilla-Perrot B, et al. Increased sensitivity of electrophysiological study by isoproterenol infusion in unexplained syncope. Int J Cardiol. 2006;106:82–87.
Chen LY, et al. Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope. J Interv Card Electrophysiol. 2005 Nov;14:99–105.
Brilakis ES, et al. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: A case series and a systematic review of the literature. Int J Cardiol. 2005;98:395–401.
Fitzpatrick A, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389–394.
McDermott D, et al. Acute myocardial infarction in patients with syncope. Can J Emerg Med. 2009;11:156–160.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brignole, M., Benditt, D.G. (2011). Cardiac Syncope. In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_13
Download citation
DOI: https://doi.org/10.1007/978-0-85729-201-8_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-200-1
Online ISBN: 978-0-85729-201-8
eBook Packages: MedicineMedicine (R0)